95252 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
#3002Compounds and their use as BACE inhibitors
#3003Nuclear transport modulators and uses thereof
#3004Annelated phenoxyacetamides
#3005GLP-1 receptor modulators
#3006EGFR inhibitor, preparation method and use thereof
#3007Diheteroaryl histone deacetylase inhibitors and their use in therapy
#3008Nonanoic and decanoic acid derivatives and uses thereof
#3009Modulators of calcium release-activated calcium channel
#3010Heteroarylamide inhibitors of TBK1
#30111-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors
#3012Dual-warhead covalent inhibitors of FGFR-4
#3013Aminopyridine compounds useful as inhibitors of protein prenylation
#3014Heterocyclic compounds as pesticides
#3015SMALL MOLECULE INHIBITORS OF NECROPTOSIS
#3016QUINAZOLINE DERIVATIVES SUBSTITUTED BY ANILINE, PREPARATION METHOD AND USE THEREOF
#3017Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
#3018Amide compounds for treatment of complement mediated disorders
#3019Glycosidase inhibitors
#3020HETEROCYCLIC RING AND CARBOCYCLIC DERIVATIVE
#3021Compositions and methods for inhibition of the JAK pathway
#3022Pyrimidines as sodium channel blockers
#3023Kinase inhibitors
#3024Therapeutic compounds as inhibitors of the orexin-1 receptor
#30251,2,4-triazine-4-amine derivatives
#3026Small molecule regulators of steroid receptor coactivators and methods of use thereof
#30271,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
#3028Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules
#3029Compounds for the inhibition of cyclophilins and uses thereof
#3030COMPOUNDS FOR THE INHIBITION OF CYCLOPHILINS AND USES THEREOF
#3031Diamide macrocycles that are FXIa inhibitors
#30322-aminopyrimidine compound and pharmaceutical composition and use thereof
#3033PYRIMIDINEDIONE COMPOUNDS
#3034Benzenesulfonyl-asymmetric ureas and medical uses thereof
#3035Indazole compounds as FGFR kinase inhibitor, preparation and use thereof
#3036Therapeutic compounds and uses thereof
#3037Benzazepine sulfonamide compounds
#3038SMALL LIPOPEPTIDOMIMETIC INHIBITORS OF GHRELIN O-ACYL TRANSFERASE
#3039Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
#3040Organic electroluminescent element, display device, lighting device, PI-conjugated compound, and light-emitting thin film
#3041Certain protein kinase inhibitors
#3042Quinazoline derivatives, compositions thereof, and use as pharmaceuticals
#3043SUBSTITUTED URACILS AS CHYMASE INHIBITORS
#3044Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
#3045Pyrazolyl guanidine FF-ATPase inhibitors and therapeutic uses thereof
#3046Compounds as CRTH2 antagonist and uses thereof
#3047Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity
#3048Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C
#3049Biaryl amide compounds as kinase inhibitors
#3050Androgen receptor modulating compounds
#3051Sulfoximine substituted quinazolines for pharmaceutical compositions
#3052Compounds
#3053Heteroaryl orexin receptor antagonists
#3054Heterocyclic compound
#3055Nampt Inhibitors
#3056N4-PHENYL-QUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
#3057ALK kinase inhibitor, and preparation method and uses thereof
#3058Inhibitors of IRAK4 activity
#3059Methods and compositions for inhibition of Ras
#3060Compounds
#3061PHARMACEUTICALLY ACTIVE PYRAZINE DERIVATIVES
#3062Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof
#3063SUBSTITUTED PYRIMIDINES AS INHIBITORS OF HIF PROLYL HYDROXYLASE
#3064Octahydrocyclopentapyrroles, their preparation and use
#3065Substituted Pyrrolidine Carboxamide Compounds
#3066Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity
#30672,4-pyrimidinediamine compounds and their uses
#30683-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1)-one derivatives as fungicides
#3069G protein-coupled receptor kinase 2 inhibitors and methods for use of the same
#3070Small molecule agonists of neurotensin receptor 1
#3071Heterocycle and carbocycle derivatives having TrkA inhibitory activity
#3072Pyrimidine derivatives for the treatment of viral infections
#3073Heterocyclic compounds as NaV channel inhibitors and uses thereof
#3074T-type calcium channel modulator and uses thereof
#3075Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof
#3076Quaternary amine compounds and antibody-drug conjugates thereof
#3077Compounds, compositions and methods
#3078PHTHALAZINONE DERIVATIVES
#3079Quinazoline derivative
#3080Pyridinyloxy- and phenyloxy-pyrazolyl compounds
#3081Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging
#30822,2,2-trifluoroethyl-thiadiazines
#3083Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same
#3084Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
#3085Forms and compositions of an ERK inhibitor
#3086Pyrrolidinone derivatives as MetAP-2 inhibitors
#3087Potent dual BRD4-kinase inhibitors as cancer therapeutics
#3088Pyrrolopyrimidine compounds as inhibitors of protein kinases
#3089TLR-independent small molecule adjuvants
#3090Ligand-directed covalent modification of protein
#3091Inhibitors of IRAK4 activity
#3092Hepatitis B antiviral agents
#3093Pyrimidine-2,4-diamine derivatives for treatment of cancer
#3094Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereof
#3095Bicyclo[3.2.1]Octyl Amide Derivatives and Uses of Same
#3096SUBSTITUTED BENZENE AND 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS
#3097Additive for imparting ultraviolet absorbency and/or high refractive index to matrix, and resin member using same
#3098Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors
#3099Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis
#3100Aminopyrimidine derivatives for use as modulators of kinase activity
#3101SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
#3102Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies
#3103Synthesis of an antiviral compound
#3104Substituted azaspiro(4.5)decane derivatives
#3105ERK inhibitors and uses thereof
#31066-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
#3107Pyrimidine carboxamides as sodium channel blockers
#3108Process for preparing pyrazoles
#31093-aryl propiolonitrile compounds for thiol labeling
#3110BIOCIDAL COATINGS AND METHODS FOR MAKING SAME
#31114,6-disubstituted aminopyrimidine derivatives have anti-HIV activity
#3112Inhibitors of histone deacetylase
#3113Compositions, methods, and systems for the synthesis and use of imaging agents
#3114Heterocyclic compounds having cholesterol 24-hydroxylase activity
#3115Inhibitors of bacterial DNA gyrase with efficacy against gram-negative bacteria
#3116Heteroaryl substituted compounds as RORγ inhibitors
#3117MTH1 inhibitors for treatment of cancer
#31183-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
#3119Process for producing alkynylketone derivative
#3120Bifunctional compounds and use for reducing uric acid levels
#31213-(Carboxyethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
#3122Estrogen receptor modulators and uses thereof
#3123Urea and amide derivatives of aminoalkylpiperazines and use thereof
#31245-acylsulfanyl-histidine compounds as precursors of the corresponding 5-sulfanylhistidines and their disulfides
#3125Imidazol- or 1,2,4-triazol-derivatives and their use
#3126BIS(ARYL)CATECHOL DERIVATIVES AS HERBICIDES
#3127Pyrazole compounds and methods of making and using same
#3128Amino compounds for treatment of complement mediated disorders
#3129Neprilysin inhibitors
#3130Heterocyclic amides as kinase inhibitors
#3131Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer
#3132Difluoromethoxy compound with low bioactivation potential for the reduction of beta-amyloid production
#3133Quinoxaline compounds and uses thereof
#3134Biotin Derivatives
#3135Protein kinase conjugates and inhibitors
#3136Substituted indole Mcl-1 inhibitors
#3137Antiviral compounds and methods using same
#3138Pyridazine compounds as JAK inhibitors
#3139Inhibitors of the fibroblast growth factor receptor
#3140Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
#3141Apelin receptor (APJ) agonists and uses thereof
#31422-amino-benzimidazole derivatives and their use as 5-lipoxygenase and/or prostaglandin E synthase inhibitors
#3143Five-membered heterocycles useful as serine protease inhibitors
#31446-substituted quinazolinone inhibitors
#3145Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
#3146N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
#3147Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
#3148Water-soluble activatable molecular probes, intermediates for the synthesis thereof and associated detection methods
#3149Pyrimidinone derivative having autotaxin-inhibitory activity
#3150MULTIVALENT RAS BINDING COMPOUNDS
#3151TrKA kinase inhibitors, compositions and methods thereof
#3152Compounds and methods for inhibiting fascin
#3153Substituted pyrimidines for inhibiting Raf kinase activity
#3154Histone demethylase inhibitors
#3155Substituted indazole derivatives active as kinase inhibitors
#3156Quinazolinone derivatives as PARP inhibitors
#3157FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS
#3158Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use
#3159Anti-depression compounds
#3160TRPV1 vanilloid receptor antagonists with a bicyclic portion
#3161Benzimidazole derivatives as kinase inhibitors
#3162Amino quinazolines as kinase inhibitors
#3163NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND
#3164Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
#3165Compositions, methods, and systems for the synthesis and use of imaging agents
#3166Substituted asymmetric ureas as modulators of ghrelin receptor activity
#3167Pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors
#3168Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredient
#3169Substituted azetidine derivatives
#3170Tetrazole-substituted arylamides as PXand PXantagonists
#3171Nuclear Transport Modulators And Uses Thereof
#3172Compositions and methods for inhibition of the JAK pathway
#3173Compounds for the treatment of HIV
#3174Inhibitors of lysine specific demethylase-1
#3175Neprilysin inhibitors
#3176Methods for treating MS using pyrimidine and pyridine compounds with BTK inhibitory activity
#3177Cyclic amine azaheterocyclic carboxamides
#3178Tetrazolones as a carboxylic acid bioisosteres
#31796-acyl-1,2,4-triazine-3,5-dione derivative and herbicides
#3180Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2
#3181Compounds
#3182HIV REPLICATION INHIBITING PYRIMIDINES
#3183COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
#3184Auristatin derivatives and conjugates thereof
#31852-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [(S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide for use in the treatment of pain associated to osteoarthritis
#3186Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
#3187Tetrazolinone compound and application thereof
#3188Compound and organic light-emitting device including the same
#3189Compounds and compositions as kinase inhibitors
#3190TrkA kinase inhibitors, compositions and methods thereof
#3191NOVEL EFFECTIVE ANTIVIRAL COMPOUNDS AND METHODS USING SAME
#3192Histone demethylase inhibitors
#3193N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof
#3194Phenyl triazole derivative and its use for modulating the GABAreceptor complex
#3195Water-soluble triazabutadienes
#3196Inhibitors of lysine specific demethylase-1
#3197Tyrosine kinase inhibitor and uses thereof
#3198Treatment of GVHD
#3199Dihydroxy aromatic heterocyclic compound
#3200Benzimidazole compounds and medical uses thereof
#3201AMINOPYRAZOLONE DERIVATIVE
#3202TrkA kinase inhibitors, compositions and methods thereof
#3203HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL
#3204Compounds useful as immunomodulators
#3205Indole derivatives for use in medicine
#3206Tetrazolinone compound and application thereof
#3207Anthracene derivative, light-emitting element using the same, and light-emitting device using the same
#3208Carboxamide derivatives and use thereof
#3209Pyrazole-substituted arylamides as P2Xand P2Xantagonists
#3210Dual inhibitor compounds for use in the treatment of neurodegenerative disorders and alzheimer's disease
#3211Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same
#3212DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#3213Pyrazole compounds and their use as T-type calcium channel blockers
#3214Light-Emitting Element, Display Device, Electronic Device, and Lighting Device
#3215Substituted indol-5-ol derivatives and their therapeutical applications
#3216Compositions, methods of use, and methods of treatment
#3217Benzimidazole derivatives and uses thereof
#32181 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitor
#3219Phenyl and benzodioxinyl substituted indazoles derivatives
#3220Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto
#3221ANTIVIRAL COMPOUNDS
#32222,4-pyrimidinediamine compounds and their uses
#3223Small molecule inhibitor of MYD88 for therapeutic treatment against alphavirus and staphylococcal enterotoxin infections and toxin exposure
#3224Pyrazolyl-substituted heteroaryls and their use as medicaments
#3225Treatments for gastrointestinal conditions
#3226Guanidine compounds and use thereof
#3227Multivalent ligands targeting VEGFR
#3228Crystal form of dabigatran etexilate mesylate and preparation method and use thereof
#3229Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#3230Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
#3231Human plasma kallikrein inhibitors
#3232Benzomorphan analogs and use thereof
#3233Treatment of brain and central nervous system tumors
#3234CDK8-CDK19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer
#3235Pyridine and pyrazine derivative for the treatment of CF
#3236Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
#3237Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine
#3238Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell
#3239Herbicidal compounds
#32401,2-substituted cyclopentanes as orexin receptor antagonists
#3241Urea derivative or pharmacologically acceptable salt thereof
#3242NEW PHENYLAZETIDINECARBOXYLATE OR -CARBOXAMIDE COMPOUNDS
#3243Combinations for the treatment of neuroblastoma
#3244Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof
#3245Fumarate analogs and uses thereof
#3246Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device
#3247Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
#32482,3,4,6-tetra-substituted benzene-1,5-diamine derivatives, preparation method therefor and medicinal use thereof
#3249Compositions useful for treating disorders related to kit
#3250Arginine methyltransferase inhibitors and uses thereof
#3251NOVEL ANNELATED PHENOXYACETAMIDES
#3252Small molecule inhibitors of G protein coupled receptor 6 kinases polypeptides
#3253Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#3254NEW BICYCLIC DERIVATIVES
#3255Annelated benzamides
#3256Uracil derivatives as AXL and c-MET kinase inhibitors
#32573-CYCLOALKYLAMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS
#3258COMPOUNDS AND THERAPEUTICAL USE THEREOF
#3259CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#3260Benzamide compounds and related methods of use
#3261Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#3262Heterocyclic compounds and their use as dopamine D1 ligands
#32632-amino-pyridine and 2-amino-pyrimidine derivatives and medicinal use thereof
#3264Disubstituted 1, 2, 4-triazine compound
#3265Hydrophobically tagged janus kinase inhibitors and uses thereof
#3266Janus kinase inhibitors and uses thereof
#3267INHIBITORS OF DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS
#3268JAK1 inhibitors
#3269ALANINE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
#3270Nitrogen-containing heteroaryl compounds and methods of use thereof
#3271Heterocyclic compounds and uses thereof
#3272Diazaspirocycloalkane and azaspirocycloalkane
#3273Enhancer of zeste homolog 2 inhibitors
#3274Antibacterial 1-indazole and 1-indole derivatives
#3275Compositions useful for treating disorders related to kit
#3276N-alkoxyamide conjugates as imaging agents
#3277Tetrahydro-benzoimidazolyl modulators of TGR5
#3278Condensed 5-oxazolidinone derivative
#3279Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
#3280Benzamides
#3281Halogenated quinazolin-THF-amines as PDE1 inhibitors
#3282Neprilysin inhibitors
#3283Amido-substituted azole compounds
#3284Spiro compound having azafluorene ring structure, light-emitting material, and organic electroluminescent device
#3285Hepatitis B core protein allosteric modulators
#3286Pyrimidone carboxamide compounds as PDE2 inhibitors
#3287PKM2 modulators and methods for their use
#3288Azepane derivatives and methods of treating hepatitis B infections
#3289Somatostatin receptor subtype 4 (SSTR4) agonists
#3290Cysteine protease inhibitors and uses thereof
#3291Neprilysin inhibitors
#3292Heterocyclic amides as kinase inhibitors
#3293Bicyclic lactams and methods of use thereof
#3294Heteroaryl compounds as BTK inhibitors and uses thereof
#3295NOVEL HETEROBICYCLIC COMPOUNDS AS KAPPA OPIOID AGONISTS
#32961-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors
#3297Pyrimidine FGFR4 inhibitors
#3298Azaspiro derivatives as TRPM8 antagonists
#3299Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists
#3300PIPERIDINE AND PIPERAZINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS AND CANCER